Who owns Sage Therapeutics?

Tip: Access positions for across all investors

Analyze quarterly positions in Sage Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Sage Therapeutics stock

Who bought or sold Sage Therapeutics this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
DekaBank Deutsche Girozentrale 22k $460k 0% Dec 2025
 View chart
Huntington National Bank 1.00 $9.000000 0% Dec 2025
 View chart

Who sold out of Sage Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
XTX Topco Sep 2025 30k $0
Advisor Group Holdings Sep 2025 4.0k $35k